ResMed Inc. $RMD Shares Sold by Corient Private Wealth LP

Corient Private Wealth LP decreased its stake in ResMed Inc. by 9.2% in the second quarter, selling 8,507 shares but still retaining 83,995 shares valued at $16.4 million. ResMed reported strong Q2 earnings of $2.95 per share and revenue of $1.46 billion, exceeding estimates, and increased its quarterly dividend to $0.66 per share. Despite insider selling by executives, institutional investors hold nearly 55% of the company, and analysts generally maintain a "Hold" rating with a consensus price